Allergan

Allergan announced a €65 million capital investment programme for 2019 to expand its laboratories and manufacturing campuses at Westport and Clonshaugh in Ireland, creating 63 new jobs at Westport.

Allergan plc agreed to acquire Elastagen Pty Ltd, a clinical-stage company developing medical device products based on recombinant tropoelastin, for an upfront payment of US$95 million plus contingent payments.

Allergan announced a €48 million investment at its Pringy, Haute-Savoie site to increase hyaluronic acid production capacity by 40% by the second half of 2020, creating about 50 jobs by 2020.

Allergan announced a €42 million investment in its Irish operations at Clonshaugh and Westport facilities to support increased manufacturing capabilities for key current and future products, including eye care and ocular implants.